These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigen. Gwinn WM; Johnson BT; Kirwan SM; Sobel AE; Abraham SN; Gunn MD; Staats HF Vaccine; 2013 Mar; 31(11):1480-9. PubMed ID: 23352329 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the immune response induced by a nasal anthrax vaccine based on the protective antigen protein in anaesthetized and non-anaesthetized mice. Sloat BR; Cui Z J Pharm Pharmacol; 2006 Apr; 58(4):439-47. PubMed ID: 16597361 [TBL] [Abstract][Full Text] [Related]
19. A plant-produced protective antigen vaccine confers protection in rabbits against a lethal aerosolized challenge with Bacillus anthracis Ames spores. Chichester JA; Manceva SD; Rhee A; Coffin MV; Musiychuk K; Mett V; Shamloul M; Norikane J; Streatfield SJ; Yusibov V Hum Vaccin Immunother; 2013 Mar; 9(3):544-52. PubMed ID: 23324615 [TBL] [Abstract][Full Text] [Related]
20. Anthrax vaccine antigen-adjuvant formulations completely protect New Zealand white rabbits against challenge with Bacillus anthracis Ames strain spores. Peachman KK; Li Q; Matyas GR; Shivachandra SB; Lovchik J; Lyons RC; Alving CR; Rao VB; Rao M Clin Vaccine Immunol; 2012 Jan; 19(1):11-6. PubMed ID: 22089245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]